Genetron Holdings Limited (NASDAQ:GTH) Up Almost 18.23% in 1 Month, But Long Term Looking …

In last trading session, Genetron Holdings Limited (NASDAQ:GTH) saw 613,252 shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $13.36 trading at $0.03 or 0.23% at ring of the bell on the day assigns it a market valuation of $1.18 Billion. That closing price of GTH’s stock is at a discount of -32.56% from its 52-week high price of $17.71 and is indicating a premium of 32.41% from its 52-week low price of $9.03. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 508.29 Million shares which gives us an average trading volume of 290.74 Million if we extend that period to 3-months.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

For Genetron Holdings Limited (GTH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.5. Splitting up the data highlights that, out of 4 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None suggested the stock as a Hold whereas 4 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.11 in the current quarter.

Wall Street analysts have assigned a consensus price target of $19.53 to the stock, which implies a rise of 46.18% to its current value. Analysts have been projecting $19 as a low price target for the stock while placing it at a high target of $20. It follows that stock’s current price would jump +49.7% in reaching the projected high whereas dropping to the targeted low would mean a loss of 42.22% for stock’s current value.

Genetron Holdings Limited (GTH) estimates and forecasts

3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $20.01 Million for the same. And 2 analysts are in estimates of company making revenue of $20.33 Million in the next quarter that will end in March 01, 2021.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0% during past 5 years. In 2020, company’s earnings growth rate is likely to be around -32.4% while estimates for its earnings growth in next 5 years are of 0%

Genetron Holdings Limited (NASDAQ:GTH)’s Major holders

Insiders are in possession of 0% of company’s total shares while institution are holding 20.48% percent of that, with stock having share float percentage of 20.48%. Investors also watch the number of corporate investors in a company very closely, which is 48 institutions for Genetron Holdings Limited that are currently holding shares of the company. Vivo Capital, LLC is the top institutional holder at GTH for having 6.34 Million shares of worth $75.7 Million. And as of September 29, 2020, it was holding 39.62% of the company’s outstanding shares.

The second largest institutional holder is Capital World Investors, which was holding about 2.47 Million shares on September 29, 2020. The number of shares represents firm’s hold over 15.45% of outstanding shares, having a total worth of $29.52 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

On the other hand, Smallcap World Fund and PGIM Jennison Health Sciences Fd are the top two Mutual Funds which own company’s shares. As of September 29, 2020, the former fund manager was holding 2472191 shares of worth $29.52 Million or 15.45% of the total outstanding shares. The later fund manager was in possession of 1.08 Million shares on October 30, 2020, making its stake of worth around $10.92 Million in the company or a holder of 6.76% of company’s stock.

This Secret NYSE Telecom Trading at $1.36 gets $35.00 Price Target by 2 Analyst!

There is a secret stock that is LOADED with opportunity for savvy investors to make a fortune!

Get all the details here >>


Latest posts